A Vasculature-Targeting Regimen of Preoperative Docetaxel with or without Bevacizumab for Locally Advanced Breast Cancer: Impact on Angiogenic Biomarkers
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.